Functional biscuits and coronary heart disease risk factors

被引:3
作者
Boobier, Wyndham James [1 ]
Baker, Julien Steven [1 ]
Hullen, Dave [1 ]
Graham, Michael R. [1 ]
Davies, Bruce [1 ]
机构
[1] Univ Glamorgan, Sch Appl Sci, Hlth & Exercise Sci Res Grp, Pontypridd CF37 1DL, M Glam, Wales
来源
BRITISH FOOD JOURNAL | 2007年 / 109卷 / 2-3期
关键词
cardiovascular disease; bakery products; personal health; food products;
D O I
10.1108/00070700710732574
中图分类号
F3 [农业经济];
学科分类号
0202 ; 020205 ; 1203 ;
摘要
Purpose - The purpose of this study is to biomedically assess biscuits designed to reduce selected risk factors for coronary heart disease, in particular serum homocysteine and glucose. Design/methodology/approach - In this study, one of the countries leading jam sandwhich biscuits was significantly modified, with particular attention being paid to sugar, fat and salt concentration. A traditional biscuit was converted to a functional food by the addition of vitamin B-12, Folic Acid, Vitamin C and Prebiotic fibre, while reducing salt and sugar. Findings - The results obtained from a clinical trial demonstrated that serum homocysteine and blood glucose were significantly decreased (P < 0.05) when the modified product and the traditional biscuit were compared. These findings confirm that a health promoting biscuit can be produced commercially, and have similar organoleptic properties as the standard high fat, high sugar and salt product. Practical implications - These findings could have significant implications to the biscuit industry, as producers of products traditionally associated with poor health. This study shows that biscuit formulations can be modified significantly, and that the resultant dough yield biscuits which can be produced under commercial conditions, be organoleptically acceptable and reduce risk factors associated with coronary heart disease. Originality/value - Moving into the twenty-first century, there is no reason why biscuit consumption should be associated with poor health. Recipe and processing modifications are possible, thanks to new and innovative raw materials and an understanding of dough rheology.
引用
收藏
页码:260 / 267
页数:8
相关论文
共 23 条
[1]   Normal blood glucose and coronary risk - Dose response effect seems consistent throughout the glycaemic continuum [J].
Barrett-Connor, E ;
Wingard, DL .
BRITISH MEDICAL JOURNAL, 2001, 322 (7277) :5-6
[2]  
BENDER DA, 1989, EUR J CLIN NUTR, V43, P289
[3]   Homocysteine lowering with folic acid and vitamin B supplements - Effects on cardiovascular disease in older adults [J].
Carlsson, Cynthia M. .
DRUGS & AGING, 2006, 23 (06) :491-502
[4]   Vitamin supplements and cardiovascular risk: Review of the randomized trials of homocysteine-lowering vitamin supplements [J].
Clarke, R ;
Armitage, J .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (03) :341-348
[5]   Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment [J].
Danaei, Goodarz ;
Lawes, Carlene M. M. ;
Hoorn, Stephen Vander ;
Murray, Christopher J. L. ;
Ezzati, Majid .
LANCET, 2006, 368 (9548) :1651-1659
[6]  
*DHSS, 1995, 46 DHSS
[7]   Homocysteine, folate and vitamin B12 in patients with coronary heart disease [J].
Genser, Dieter ;
Prachar, Herbert ;
Hauer, Rene ;
Halbmayer, Walter-Michael ;
Mlczoch, Johannes ;
Elmadfa, Ibrahim .
ANNALS OF NUTRITION AND METABOLISM, 2006, 50 (05) :413-419
[8]   Homocysteine and vascular disease [J].
Hankey, GJ ;
Eikelboom, JW .
LANCET, 1999, 354 (9176) :407-413
[9]   Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults [J].
He, JA ;
Ogden, LG ;
Vupputuri, S ;
Bazzano, LA ;
Loria, C ;
Whelton, PK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2027-2034
[10]  
LANDGREN F, 1995, J INTERNAL MEDICONE, V237, P281